Riversedge Advisors’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$399K Buy
1,765
+19
+1% +$4.03K 0.05% 186
2026
Q2
$377K Buy
1,746
+217
+14% +$41.5K 0.05% 162
2026
Q1
$280K Buy
1,529
+241
+19% +$44.4K 0.05% 155
2025
Q4
$227K Buy
+1,288
New +$210K 0.04% 182

Other funds holding BIIB

Riversedge Advisors's BIIB Position: Q3 2026 in Review

Riversedge Advisors increased its Biogen (BIIB) stake by 1.1% in Q3 2026, buying an estimated $4.03K and bringing the position to 1,765 shares worth $399K. The position accounts for 0.05% of the portfolio, ranked #186.

Riversedge Advisors first reported a position in BIIB in Q4 2025 and has held it in 4 quarters since. 1,056 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

  • Riversedge Advisors held 1,765 shares of Biogen worth $399K as of Q3 2026.
  • Riversedge Advisors bought 19 Biogen shares in Q3 2026, an estimated $4.03K.
  • Biogen made up 0.05% of Riversedge Advisors's portfolio in Q3 2026, its #186 holding.
  • Riversedge Advisors first reported a position in Biogen in Q4 2025 and has held it in 4 quarters since.
  • 1,056 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on Riversedge Advisors's 13F filing for Q3 2026, filed 9 Oct 2026.